Lv1
100 积分 2026-04-21 加入
A Phase 1 Dose Escalation Study of Milademetan in Combination with 5-Azacitidine (AZA) in Patients with Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
5天前
已关闭
Gadd45 in DNA Demethylation and DNA Repair
27天前
已完结
TWIST1 bridges p53 and MDM2 and impairs the efficacy of MDM2 inhibitors
1个月前
已完结
The physiological relevance of downstream effectors of p53 activity
1个月前
已完结
Role of Wnt/β-catenin pathway in cancer drug resistance: Insights into molecular aspects of major solid tumors
1个月前
已完结
A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies
2个月前
已完结
Expression variations of DNA damage response genes ATM and ATR in blood cancer patients
2个月前
已完结
Characterize Biomarkers and Mechanisms of Resistance for MDM2 Inhibitors in AML
2个月前
已关闭
Brigimadlin (BI-907828) and napabucasin (BBI608) cooperatively trigger apoptosis in chronic lymphocytic leukemia cells by simultaneous inhibition of MDM2 and STAT3
2个月前
已完结
Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
2个月前
已完结